
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
Nexture acquires Sipral as “buy-and-build” strategy gathers pace
Key takeaways
- Nexture acquires Sipral to expand its value-added ingredients portfolio, adding strengths in fat-based creams, fillings, and nut-based ingredients.
- The deal advances Nexture’s “buy-and-build” strategy, backed by Investindustrial, following the 2025 acquisition of Frulact.
- Nexture expects major scale-up post-acquisitions, with factories increasing from 8 to 29 and the workforce growing to over 2,800 employees.

Nexture, a global food ingredients manufacturer, has acquired Italian ingredients producer Sipral. The move is intended to broaden Nexture’s portfolio in semi-finished, value-added ingredients and add capabilities in fat-based creams and fillings and nut-based ingredients.
“By adding Sipral’s expertise in value-added ingredients to our market presence worldwide, we are not only expanding our product portfolio but are also strengthening our ability to deliver exceptional value to customers across different channels. This strategic acquisition is a clear example of Nexture’s desire to contribute to the expansion and promotion of Italian know-how and high-quality ingredients worldwide,” says Gabriele Del Torchio, Nexture’s CEO.

Nexture’s “buy-and-build” strategy also saw it acquire Frulact, a natural ingredients solution platform, in November 2025. This strategy is designed with the operational support of Investindustrial, the investment firm behind Nexture.
Nexture CEO Gabriele Del Torchio.
Before Investindustrial’s involvement, Nexture included CSM Ingredients and generated €517 million (US$604 million) in sales. With the investment firm’s backing, it has evolved into a global value-added ingredients group, with estimated annual revenues of approximately €1.2 billion (US$1.4 billion), pro forma for the acquisitions of Frulact and Sipral.
After completion of the acquisitions of Frulact and Sipral, the group’s industrial footprint is expected to expand from eight factories to 29 worldwide, including two in North America, four in Africa, one in Asia, and the remaining 22 across eight European countries.
Nexture’s R&D centres are expected to increase from eight facilities to 21, while the workforce will grow from 1,400 to over 2,800 employees.
Sipral Padana
Headquartered in Bagnolo Cremasco, Crema, Italy, Sipral employs over 130 people and operates five production facilities across the country, developing fat-based creams and fillings, fats and oils, nut-based ingredients, artisanal gelato ingredients, bakery mixes, and ready-to-use breakfast solutions.
The company is expected to generate revenue in excess of €80 million for the year ending December 31, 2025, and sells its products in over 20 countries worldwide through a multi-channel approach. Its diversified offering addresses a broad range of customer needs, leveraging brands including Marcagel, Effedue, Facci, Creami, Casa della Mandorla, and Living Breakfast.
“We are very excited to join Nexture and its shareholder, Investindustrial. The transaction represents an extraordinary opportunity for Sipral to accelerate its growth trajectory internationally and expand its reach across Europe and beyond. The combination with Nexture will enable us to offer our customers an even more comprehensive range of high-quality, value-added ingredients,” says Gianpietro Corbari, Sipral’s CEO.
Completion of the transaction is subject to customary closing conditions, including regulatory approvals, and is currently expected to take place in the first half of 2026.






